Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery & Development), by Type, by End Use, by Region, and Segment Forecasts, 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The global base editing market size was estimated at USD 228.2 million in 2024 and is projected to reach USD 681.2 million, growing at a CAGR of 13.46% from 2025 to 2033.
Rising prevalence of chronic & rare diseases, increased application of genomic research in therapeutics, and increased government funding & growing focus on genomic studies are the factors driving the base editing industry.
Advancement in Base Editing Technology
Base editing (BE), a CRISPR-Cas9 genome editing technology, offers potential therapeutic strategies against diseases. Base editing has shown significant potential in correcting genetic mutations associated with immunodeficiency disorders and chronic diseases such as cardiovascular disorders, metabolic conditions, and certain types of cancer.
Moreover, base editing sensor libraries enable high-throughput screening and functional analysis of cancer-associated single nucleotide variants. The rising number of cancer cases worldwide increases the demand for novel therapeutics. For instance, in 2022, cancer was one of the leading causes of death globally, with 20 million new cases and 9.7 million deaths, according to the National Cancer Institute. By 2040, it is projected that cancer cases will reach 29.9 million, with 15.3 million cancer-related deaths.
Recent advancements in base editing technology have shown significant progress in crop genetic improvement. For instance, according to a study published in Genome Biology in February 2024, scientists have developed highly efficient base editors for cotton plants. The GhABE8e base editor exhibited 99.9% editing efficiency compared to GhABE7.10, which had 64.9% efficiency, with no off-target editing detected. Such studies provide an important technical platform and genetic information for studying and creating ideal plant architecture.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
Market Dynamics
Market driver analysis
- Rising prevalence of chronic and rare diseases
- Increased application of genomic research in therapeutics
- Increasing government funding & growing focus on genomic studies
Market restraint analysis
- Ethical and safety concerns related to base editing technologies
Base Editing Market Analysis Tools
- Industry Analysis - Porter's
- PESTEL Analysis
Companies Featured
- Danaher Corporation
- Merck KGaA
- Revvity
- Maravai LifeSciences
- GenScript
- Beam Therapeutics
- Intellia Therapeutics, Inc.
- Cellectis
- ElevateBio
- Creative Biogene
- Bio Palette Co., Ltd
Global Base Editing Market Report Segmentation
Products & Services Outlook (Revenue, USD Million, 2021-2033)
- Product
- Platform
- Kits & Reagents
- Plasmids
- Base Editing Libraries
- Services
- gRNA Design
- Cell Line Engineering
Application Outlook (Revenue, USD Million, 2021-2033)
- Drug Discovery & Development
- Agriculture
- Veterinary
Type Outlook (Revenue, USD Million, 2021-2033)
- DNA Base Editing
- RNA Base Editing
End Use Outlook (Revenue, USD Million, 2021-2033)
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
For more information about this report visit https://www.researchandmarkets.com/r/xqb8ou
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
